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kinase (CASK) has been recently identified as a potent new protein inter-
acting with Cav1.2 channel. Nevertheless, despite the fact that CASK is
expressed in cardiac cells, to this date, no functional experiments have
been performed to investigate the role of CASK on Cav1.2 channels
regulation.
Methods and Results: Full length or the C-terminal truncated
(2024stop) Cavα1c subunit, both expressed in cardiac cells, was co-
expressed with Cavβ2 and Cavα2-δ1 subunits in TsA-201 cells. In addi-
tion scramble or silencer of CASK protein was co-transfected with Cav1.2
channels. Barium currents (IBa) and calcium current (ICa) were recorded
under voltage-clamp conditions using the whole-cell configuration. After
72 hours post-transfection, the cells silenced for CASK, expressing either
the full length or 2024stop Cavα1c subunits, show an increase of ICa. In
contrast, in similar condition of transfection, the IBa current is only
increased in the condition with the C-terminal truncated Cavα1c subunit
suggesting that the C-terminal part of Cavα1c subunit counteracts the
CASK silencing effect. Interestingly, the C-terminal part of Cavα1c sub-
unit masks an interacting motif for the calcium-dependent serine-threonine
phosphatase: calcineurin. One hour incubation with cyclosporin A, a spe-
cific inhibitor of calcineurin phosphatase, blunts the CASK silencing
effect on IBa with the C-terminal truncated part of Cavα1c subunit
bringing out the key role of calcineurin in the mechanism of Cav1.2 chan-
nels regulation by CASK.
Conclusion: In the present study, we highlight CASK protein as a novel
regulator of voltage-gated calcium channel Cav1.2 via the calcineurin.
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The cardioprotective effects through prevention of cardiac arrhythmias of
long-chain polyunsaturated fatty acids of the n-3 series (PUFAs) have been
demonstrated over the last 40 years. The main n-3 PUFAs are eicosapentae-
noic acid (C20:5 n-3, EPA) and docosahexaenoic acid (C22:6 n-3, DHA) and
both are highly peroxidable due to the presence of skipped dienes. The effects
of n-3 PUFAs on cardiac function are controversial, notably due to lack of
information on the mechanisms involved. Particularly, it is not well under-
stood which is the active lipid: the PUFA or one of its oxygenated metabo-
lites. Neuroprostanes are lipid mediators produced by non-enzymatic free
radical peroxidation of DHA. Plasmatic 4(RS)-4-F4t-NeuroP concentration is
negatively correlated with the risk of atherosclerosis suggesting a beneficial
active role in some cardiovascular disease. In this study, we show that oxi-
dized DHA and more specifically the isomers 4(RS)-4-F4t-NeuroP possess
strong anti-arrhythmic properties (AAP) in isolated ventricular cardiomyo-
cytes and in vivo in post-myocardial infarcted mice. Calcium imaging and bio-
chemical experiments indicate that arrhythmias are associated with Ca2+ leak
from the sarcoplasmic reticulum following oxidation and phosphorylation of
the type 2 ryanodine receptor (RyR2) leading to dissociation of the FKBP12.6/
RyR2 complex. DHA per se has no AAP. Oxidized DHA as well as 4(RS)-4-
F4t-NeuroP prevented posttranslational modifications of the RyR2 and stabi-
lized the complex FKBP12.6/RyR2 to normalize Ca2+. This effect of 4(RS)-
4-F4t-NeuroP was further associated with the suppression in vitro and in vivo
of cardiac arrhythmias. Our findings, demonstrates 4(RS)-4-F4t-NeuroP as a
mediator of the AAP that exerts cardioprotective characteristics of DHA.
